Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
European Heart Journal. Cardiovascular Pharmacotherapy|June 25, 2024
Comparative cardiovascular and renal effectiveness of empagliflozin and dapagliflozin: Scandinavian cohort studyArvid Engström, Jonas Söderling, Anders Hviid, et al.
Diabetes, Obesity & Metabolism|April 17, 2026
Use of Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort StudyArvid Engström, Henrik Svanström, Anders Hviid, et al.
BMJ (Clinical Research Ed.)|August 31, 2019
Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort studyBjörn Pasternak, Peter Ueda, Björn Eliasson, et al.
Diabetes Care|April 17, 2020
Use of Glucagon-Like Peptide 1 Receptor Agonists and Risk of Serious Renal Events: Scandinavian Cohort StudyBjörn Pasternak, Viktor Wintzell, Björn Eliasson, et al.
BMJ (Clinical Research Ed.)|May 1, 2020
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort studyBjörn Pasternak, Viktor Wintzell, Mads Melbye, et al.
Diabetologia|July 13, 2021
Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort studyPeter Ueda, Viktor Wintzell, Mads Melbye, et al.
Journal of the American College of Cardiology|August 31, 2018
External Validation of the DAPT Score in a Nationwide PopulationPeter Ueda, Tomas Jernberg, Stefan James, et al.
Journal of Cardiovascular Pharmacology|October 31, 2022
Lipid Lowering in "Very High Risk" Patients Undergoing Coronary Artery Bypass Surgery and Its Projected Reduction in Risk for Recurrent Vascular Events: A Monte Carlo Stepwise Simulation ApproachSalil Deo, Peter Ueda, Adil Muhammad Sheikh, et al.
The Western Journal of Emergency Medicine|June 15, 2017
Index to Predict In-hospital Mortality in Older Adults after Non-traumatic Emergency Department IntubationsKei Ouchi, Samuel Hohmann, Tadahiro Goto, et al.
Diabetes, Obesity & Metabolism|November 5, 2021
The comparative cardiovascular and renal effectiveness of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A Scandinavian cohort studyPeter Ueda, Viktor Wintzell, Elisabeth Dahlqwist, et al.
Pageof 9